A clinical pharmacologist is assisting the critical care team with dosing adjustments for patients experiencing severe hemodynamic and metabolic derangements. The relationship between hepatic blood flow (), intrinsic hepatocellular clearance (), and the fraction of unbound drug () mathematically dictates the disposition of hepatically cleared medications. Carefully evaluate the following patient scenarios and drug properties. Pair each specific clinical scenario with its most accurate primary pharmacokinetic consequence.
- Intravenous administration of a high-extraction ratio drug (e.g., propofol) during acute cardiogenic shockClearance is markedly reduced because elimination is predominantly rate-limited by hepatic blood perfusion.
- Intravenous administration of a low-extraction ratio drug (e.g., ropivacaine) following long-term therapy with a potent CYP450 enzyme inducerClearance is markedly enhanced because elimination is predominantly rate-limited by the liver's intrinsic metabolic capacity.
- Intravenous administration of a highly protein-bound, low-extraction ratio drug (e.g., phenytoin) in a patient with nephrotic syndrome and severe hypoalbuminemiaTotal systemic clearance increases, leading to a lower total steady-state concentration, while the pharmacologically active free drug concentration remains unchanged.
- Oral administration of a high-extraction ratio drug (e.g., propranolol) in a patient with advanced liver cirrhosis and severe portosystemic shuntingSystemic bioavailability is substantially increased because the medication evades first-pass metabolism, leading to a much higher area under the curve (AUC).
Cevap
1 matches with hepatic blood perfusion rate-limitation, 2 matches with intrinsic metabolic capacity enhancement, 3 matches with increased total clearance but unchanged free concentration, and 4 matches with increased systemic bioavailability due to evaded first-pass metabolism.
The matching correctly links physiological derivations of the general hepatic clearance equation to specific clinical perturbations, recognizing that high-extraction drugs are flow-limited () while low-extraction drugs are capacity- and binding-limited ().
Adım Adım Çözüm
Anahtar Kavram
Hepatic Clearance Kinetics, Extraction Ratios, and Protein Binding